 | • レポートコード：GIR-107A14284 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、低酸素誘導因子1アルファ阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。低酸素誘導因子1アルファ阻害剤の種類別市場規模（BC-001、CASI-2ME2、CRLX-101、その他）、用途別市場規模（固形腫瘍、急性骨髄性白血病、結腸直腸癌、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・低酸素誘導因子1アルファ阻害剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aileron Therapeutics, Inc.、CASI Pharmaceuticals Inc.、Cerulean Pharma, Inc.、F. Hoffmann-La Roche Ltd.、InterMed Discovery GmbH、OncoImmune, Inc.、Peloton Therapeutics, Inc.、RXi Pharmaceuticals Corporation、Sorrento Therapeutics, Inc.、Transcriptogen Ltd、Vascular Biogenics Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：BC-001、CASI-2ME2、CRLX-101、その他 ・用途別分析2016年-2026年：固形腫瘍、急性骨髄性白血病、結腸直腸癌、その他 ・低酸素誘導因子1アルファ阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・低酸素誘導因子1アルファ阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・低酸素誘導因子1アルファ阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・低酸素誘導因子1アルファ阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・低酸素誘導因子1アルファ阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hypoxia Inducible Factor 1 Alpha Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Hypoxia Inducible Factor 1 Alpha Inhibitor size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Hypoxia Inducible Factor 1 Alpha Inhibitor market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Hypoxia Inducible Factor 1 Alpha Inhibitor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
BC-001
CASI-2ME2
CRLX-101
Others
Market segment by Application can be divided into
Solid Tumor
Acute Myelocytic Leukemia
Colorectal Cancer
Others
The key market players for global Hypoxia Inducible Factor 1 Alpha Inhibitor market are listed below:
Aileron Therapeutics, Inc.
CASI Pharmaceuticals Inc.
Cerulean Pharma, Inc.
F. Hoffmann-La Roche Ltd.
InterMed Discovery GmbH
OncoImmune, Inc.
Peloton Therapeutics, Inc.
RXi Pharmaceuticals Corporation
Sorrento Therapeutics, Inc.
Transcriptogen Ltd
Vascular Biogenics Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Hypoxia Inducible Factor 1 Alpha Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hypoxia Inducible Factor 1 Alpha Inhibitor, with price, sales, revenue and global market share of Hypoxia Inducible Factor 1 Alpha Inhibitor from 2019 to 2021.
Chapter 3, the Hypoxia Inducible Factor 1 Alpha Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hypoxia Inducible Factor 1 Alpha Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hypoxia Inducible Factor 1 Alpha Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Hypoxia Inducible Factor 1 Alpha Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 BC-001
1.2.3 CASI-2ME2
1.2.4 CRLX-101
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Solid Tumor
1.3.3 Acute Myelocytic Leukemia
1.3.4 Colorectal Cancer
1.3.5 Others
1.4 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size & Forecast
1.4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Value (2016-2026))
1.4.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume (2016-2026)
1.4.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity Analysis
1.5.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Total Production Capacity (2016-2026)
1.5.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Drivers
1.6.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Restraints
1.6.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Trends Analysis
2 Manufacturers Profiles
2.1 Aileron Therapeutics, Inc.
2.1.1 Aileron Therapeutics, Inc. Details
2.1.2 Aileron Therapeutics, Inc. Major Business
2.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.1.4 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 CASI Pharmaceuticals Inc.
2.2.1 CASI Pharmaceuticals Inc. Details
2.2.2 CASI Pharmaceuticals Inc. Major Business
2.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.2.4 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Cerulean Pharma, Inc.
2.3.1 Cerulean Pharma, Inc. Details
2.3.2 Cerulean Pharma, Inc. Major Business
2.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.3.4 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business
2.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.4.4 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 InterMed Discovery GmbH
2.5.1 InterMed Discovery GmbH Details
2.5.2 InterMed Discovery GmbH Major Business
2.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.5.4 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 OncoImmune, Inc.
2.6.1 OncoImmune, Inc. Details
2.6.2 OncoImmune, Inc. Major Business
2.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.6.4 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Peloton Therapeutics, Inc.
2.7.1 Peloton Therapeutics, Inc. Details
2.7.2 Peloton Therapeutics, Inc. Major Business
2.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.7.4 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 RXi Pharmaceuticals Corporation
2.8.1 RXi Pharmaceuticals Corporation Details
2.8.2 RXi Pharmaceuticals Corporation Major Business
2.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.8.4 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Sorrento Therapeutics, Inc.
2.9.1 Sorrento Therapeutics, Inc. Details
2.9.2 Sorrento Therapeutics, Inc. Major Business
2.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.9.4 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Transcriptogen Ltd
2.10.1 Transcriptogen Ltd Details
2.10.2 Transcriptogen Ltd Major Business
2.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.10.4 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Vascular Biogenics Ltd.
2.11.1 Vascular Biogenics Ltd. Details
2.11.2 Vascular Biogenics Ltd. Major Business
2.11.3 Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
2.11.4 Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Manufacturer
3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hypoxia Inducible Factor 1 Alpha Inhibitor
3.4 Market Concentration Rate
3.4.1 Top 3 Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturer Market Share
3.4.2 Top 6 Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturer Market Share
3.5 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hypoxia Inducible Factor 1 Alpha Inhibitor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Region
4.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Region (2016-2026)
4.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2016-2026)
4.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026)
4.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026)
4.4 Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026)
4.5 South America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026)
4.6 Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Type (2016-2026)
5.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type (2016-2026)
5.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Application (2016-2026)
6.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Application (2016-2026)
6.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2026)
7.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2026)
7.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Country
7.3.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Country (2016-2026)
7.3.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2026)
8.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2026)
8.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Country
8.3.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Country (2016-2026)
8.3.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2026)
9.2 Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2026)
9.3 Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Region
9.3.1 Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2026)
10.2 South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2026)
10.3 South America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Country
10.3.1 South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Country (2016-2026)
10.3.2 South America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2026)
11.2 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2026)
11.3 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Country
11.3.1 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Typical Distributors
12.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Application, (USD Million), 2021-2026
Table 3. Aileron Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Aileron Therapeutics, Inc. Major Business
Table 5. Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 6. Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CASI Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 8. CASI Pharmaceuticals Inc. Major Business
Table 9. CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 10. CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cerulean Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Cerulean Pharma, Inc. Major Business
Table 13. Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 14. Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. F. Hoffmann-La Roche Ltd. Major Business
Table 17. F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 18. F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. InterMed Discovery GmbH Basic Information, Manufacturing Base and Competitors
Table 20. InterMed Discovery GmbH Major Business
Table 21. InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 22. InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. OncoImmune, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. OncoImmune, Inc. Major Business
Table 25. OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 26. OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Peloton Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Peloton Therapeutics, Inc. Major Business
Table 29. Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 30. Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. RXi Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 32. RXi Pharmaceuticals Corporation Major Business
Table 33. RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 34. RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sorrento Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Sorrento Therapeutics, Inc. Major Business
Table 37. Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 38. Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Transcriptogen Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Transcriptogen Ltd Major Business
Table 41. Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 42. Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Vascular Biogenics Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Vascular Biogenics Ltd. Major Business
Table 45. Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Services
Table 46. Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 48. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Hypoxia Inducible Factor 1 Alpha Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Hypoxia Inducible Factor 1 Alpha Inhibitor Production Site of Key Manufacturer
Table 52. Hypoxia Inducible Factor 1 Alpha Inhibitor New Entrant and Capacity Expansion Plans
Table 53. Hypoxia Inducible Factor 1 Alpha Inhibitor Mergers & Acquisitions in the Past Five Years
Table 54. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2016-2021e) & (K Pcs)
Table 55. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2021-2026) & (K Pcs)
Table 56. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2021e) & (K Pcs)
Table 59. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2021-2026) & (K Pcs)
Table 60. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type (2016-2021e) & (USD/Pcs)
Table 63. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type (2021-2026) & (USD/Pcs)
Table 64. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2021e) & (K Pcs)
Table 65. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2021-2026) & (K Pcs)
Table 66. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Application (2016-2021e) & (USD/Pcs)
Table 69. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Application (2021-2026) & (USD/Pcs)
Table 70. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2016-2021e) & (K Pcs)
Table 71. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2021-2026) & (K Pcs)
Table 72. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2021e) & (K Pcs)
Table 75. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2021-2026) & (K Pcs)
Table 76. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2021e) & (K Pcs)
Table 77. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2021-2026) & (K Pcs)
Table 78. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2016-2021e) & (K Pcs)
Table 79. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2021-2026) & (K Pcs)
Table 80. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2021e) & (K Pcs)
Table 83. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2021-2026) & (K Pcs)
Table 84. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2021e) & (K Pcs)
Table 85. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2021e) & (K Pcs)
Table 93. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2021-2026) & (K Pcs)
Table 94. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2016-2021e) & (K Pcs)
Table 95. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2021-2026) & (K Pcs)
Table 96. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2021e) & (K Pcs)
Table 99. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2021-2026) & (K Pcs)
Table 100. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2021e) & (K Pcs)
Table 101. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2016-2021e) & (K Pcs)
Table 109. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2021-2026) & (K Pcs)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Hypoxia Inducible Factor 1 Alpha Inhibitor Typical Distributors
Table 113. Hypoxia Inducible Factor 1 Alpha Inhibitor Typical Customers
List of Figures
Figure 1. Hypoxia Inducible Factor 1 Alpha Inhibitor Picture
Figure 2. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type in 2020
Figure 3. BC-001
Figure 4. CASI-2ME2
Figure 5. CRLX-101
Figure 6. Others
Figure 7. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application in 2020
Figure 8. Solid Tumor
Figure 9. Acute Myelocytic Leukemia
Figure 10. Colorectal Cancer
Figure 11. Others
Figure 12. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (2016-2026) & (K Pcs)
Figure 15. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Hypoxia Inducible Factor 1 Alpha Inhibitor Market Drivers
Figure 19. Hypoxia Inducible Factor 1 Alpha Inhibitor Market Restraints
Figure 20. Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trends
Figure 21. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Manufacturer in 2020
Figure 22. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Manufacturer in 2020
Figure 23. Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region (2016-2026)
Figure 27. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Region (2016-2026)
Figure 28. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026) & (USD Million)
Figure 29. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026) & (USD Million)
Figure 31. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2016-2026) & (USD Million)
Figure 33. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2016-2026)
Figure 34. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Type (2016-2026)
Figure 35. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2016-2026)
Figure 37. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Application (2016-2026)
Figure 38. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2016-2026)
Figure 40. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2016-2026)
Figure 41. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2016-2026)
Figure 42. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2016-2026)
Figure 43. United States Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2016-2026)
Figure 47. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2016-2026)
Figure 48. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2016-2026)
Figure 49. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2016-2026)
Figure 50. Germany Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Region (2016-2026)
Figure 59. China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2016-2026)
Figure 66. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2016-2026)
Figure 67. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2016-2026)
Figure 68. South America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
低酸素誘導因子1アルファ阻害剤市場：世界及び中国市場分析・予測（～2024年） Hypoxia Inducible Factor 1 Alpha Inhibitor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hypoxia Inducible Factor 1 Alpha Inhibitor industry with a focus on the Chinese market. The report provides key statistics on the marke…- 世界の抗血友病因子・フォンウィルブランド因子複合体市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor & von Willebrand Factor Complex market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor Receptor Superfamily Member 9 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 世界のプラスミノーゲンアクチベーター阻害剤1市場 2021：企業別、地域別、種類・用途別 The Plasminogen Activator Inhibitor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の腫瘍壊死因子阻害薬市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor Inhibitors Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…